Thirty-day outcome and vascular complications after transarterial aortic valve implantation using both Edwards SAPIEN™ and Medtronic CoreValve® bioprostheses in a mixed population

  • Tchetche D
  • Dumonteil N
  • Sauguet A
 et al. 
  • 40

    Readers

    Mendeley users who have this article in their library.
  • 113

    Citations

    Citations of this article.

Abstract

Aims: Transcatheter aortic valve implantation (TAVI) is performed through a transarterial approach with encouraging results in «one-type valve» registries. We report 30-day data from a mixed population of patients treated with either Medtronic CoreValve® (MCV) or Edwards SAPIEN™ (ES) valves.Methods and results: Forty-five patients had TAVI via the transarterial approach (21 MCV and 24 ES). Mean age was 81.8±4.2 years, Logistic EuroSCORE was 25.2±8.4%. Procedural success rate was 97.8%. In-hospital death rate was 4.4%. Vascular complication rate was 8.9%. Of MCV patients, 28.6% had a permanent pacemaker vs. 4.2% of ES patients; p=0.02. No additional deaths were observed between discharge and 30 days. NYHA functional class was improved at 30-days: 2.07±0.4 vs. 3.09±0.05, p

Author-supplied keywords

  • Edwards SAPIEN™
  • Medtronic CoreValve®
  • Mixed population
  • Transarterial TAVI

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • Didier Tchetche

  • Nicolas Dumonteil

  • Antoine Sauguet

  • Fleur Descoutures

  • Andre Luz

  • Olivier Garcia

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free